TLDR Higher FABP4 levels may help diagnose androgenetic alopecia early.
This study investigated the serum levels of fatty acid-binding protein 4 (FABP4) in patients with androgenetic alopecia (AGA), involving 30 male and 20 female patients, compared to 30 healthy volunteers. The research found that AGA patients had significantly higher levels of FABP4 than the control group. The elevated FABP4 levels suggested a potential role in the pathogenesis of AGA and indicated that FABP4 could serve as a biomarker for early diagnosis of the condition, with high sensitivity, specificity, and accuracy.
September 2023 in “Medicine” The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.
1 citations,
October 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” Printing human stem cells and a special matrix during surgery can help grow new skin and hair-like structures in rats.
21 citations,
March 2018 in “Experimental Dermatology” The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.
1 citations,
April 2023 in “Frontiers in Immunology” New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.
September 2023 in “Frontiers in Medicine” The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.
